These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34482357)

  • 1. Live Combined B. subtilis and E. faecium Alleviate Liver Inflammation, Improve Intestinal Barrier Function, and Modulate Gut Microbiota in Mice with Non-Alcoholic Fatty Liver Disease.
    Jiang J; Xiong J; Ni J; Chen C; Wang K
    Med Sci Monit; 2021 Sep; 27():e931143. PubMed ID: 34482357
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Huang J; Huang J; Yin T; Lv H; Zhang P; Li H
    J Microbiol Biotechnol; 2021 Feb; 31(2):181-188. PubMed ID: 33144552
    [No Abstract]   [Full Text] [Related]  

  • 3. Enterococcus faecium R-026 combined with Bacillus subtilis R-179 alleviate hypercholesterolemia and modulate the gut microbiota in C57BL/6 mice.
    Huang J; Xu Y; Wang M; Yu S; Li Y; Tian H; Zhang C; Li H
    FEMS Microbiol Lett; 2023 Jan; 370():. PubMed ID: 37960899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of Ilexhainanoside D and ilexsaponin A
    Zhao W; Xiao M; Yang J; Zhang L; Ba Y; Xu R; Liu Z; Zou H; Yu P; Wu X; Chen X
    Phytomedicine; 2019 Oct; 63():153039. PubMed ID: 31387054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Live Combined
    Pi X; Teng W; Fei D; Zhao G; Liu W
    Front Cell Infect Microbiol; 2022; 12():821662. PubMed ID: 35223547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
    Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
    Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
    Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
    Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXO4 ameliorates alcohol-induced chronic liver injury via inhibiting NF-κB and modulating gut microbiota in C57BL/6J mice.
    Sang L; Kang K; Sun Y; Li Y; Chang B
    Int Immunopharmacol; 2021 Jul; 96():107572. PubMed ID: 33798806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation.
    Gao LL; Ma JM; Fan YN; Zhang YN; Ge R; Tao XJ; Zhang MW; Gao QH; Yang JJ
    Int J Biol Macromol; 2021 Jul; 183():1379-1392. PubMed ID: 33992651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis.
    Liu X; Sun R; Li Z; Xiao R; Lv P; Sun X; Olson MA; Gong Y
    Arch Biochem Biophys; 2021 Oct; 711():109019. PubMed ID: 34478730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
    Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
    Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schisantherin A alleviates non-alcoholic fatty liver disease by restoring intestinal barrier function.
    Yu S; Jiang J; Li Q; Liu X; Wang Z; Yang L; Ding L
    Front Cell Infect Microbiol; 2022; 12():855008. PubMed ID: 36132991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smilax china L. flavonoid alleviates HFHS-induced inflammation by regulating the gut-liver axis in mice.
    Li X; Chu L; Liu S; Zhang W; Lin L; Zheng G
    Phytomedicine; 2022 Jan; 95():153728. PubMed ID: 34561124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
    Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
    Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation.
    Zhao Z; Chen L; Zhao Y; Wang C; Duan C; Yang G; Niu C; Li S
    Appl Microbiol Biotechnol; 2020 Jun; 104(12):5273-5282. PubMed ID: 32335723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.